Logo
x

Search category

Subscribe Now

maintenance treatment

Regeneron and Sanofi's Dupixent (dupilumab) Receive the US FDA's Approval as an Add-On Maintenance Treatment to Treat Moderate-To-Severe Asthma

Regeneron and Sanofi's Dupixent (dupilumab) Receive the US FDA's Approval as an Add-On Maintenance Treatment to Treat Moderate-To-...

  • October 21, 2021
Verona Initiates P-III ENHANCE Studies Evaluating Nebulized Ensifentrine for the Maintenance Treatment of COPD

Verona Initiates P-III ENHANCE Studies Evaluating Nebulized Ensifentrine for the Maintenance Treatment of COPD

  • September 24, 2020
AstraZeneca's Breztri Aerosphere Receives the US FDA's Approval for the Maintenance Treatment of COPD

AstraZeneca's Breztri Aerosphere Receives the US FDA's Approval for the Maintenance Treatment of COPD

  • July 24, 2020
GSK's Zejula (niraparib) Receives the US FDA's Approval as 1L Monotherapy Maintenance Treatment for Women with Advanced Ovarian Cancer Regardless of Biomarker Status

GSK's Zejula (niraparib) Receives the US FDA's Approval as 1L Monotherapy Maintenance Treatment for Women with Advanced Ovarian Ca...

  • April 30, 2020
EMD Serono and Pfizer's Bavencio (avelumab) Receive the US FDA's Breakthrough Therapy Designation as 1L Maintenance Treatment of Locally Advanced or Metastatic Urothelial Carcinoma

EMD Serono and Pfizer's Bavencio (avelumab) Receive the US FDA's Breakthrough Therapy Designation as 1L Maintenance Treatment of L...

  • April 9, 2020
GSK Reports the Acceptance of EMA's MAA for Zejula (niraparib) as 1L Maintenance Treatment for Platinum-Responsive Advanced Ovarian Cancer

GSK Reports the Acceptance of EMA's MAA for Zejula (niraparib) as 1L Maintenance Treatment for Platinum-Responsive Advanced Ovaria...

  • February 27, 2020
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2024 PharmaShots - All Rights Reserved.